NL
HOLX

NorthAvenue LLC’s Hologic HOLX Stock Holding History

NorthAvenue LLC’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$149 – 313
2025
Q4 		$149 Buy
+2
New +$146 ﹤0.01% 355

Other funds holding HOLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

NorthAvenue LLC's HOLX Position: Q1 2026 in Review

NorthAvenue LLC sold out of Hologic (HOLX) in Q1 2026, closing a stake of 2 shares — an estimated $149 sold.

NorthAvenue LLC first reported a position in HOLX in Q4 2025 and held it in 1 quarter. The position peaked at $149 in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • NorthAvenue LLC reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • NorthAvenue LLC sold 2 Hologic shares in Q1 2026, an estimated $149.
  • NorthAvenue LLC first reported a position in Hologic in Q4 2025 and held it in 1 quarter.
  • NorthAvenue LLC's Hologic position peaked at $149 in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.